학술논문

Zolbetuximab + CAPOX in 1L claudin-18.2+(CLDN18.2+)/HER2-locally advanced (LA) or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: Primary phase 3 results from GLOW.
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; MAR 20 2023, 41 36_SUPPL, p405736-p405736, 1p. Supplement: 36_
Subject
Language
English
ISSN
15277755